Цитирование
Yusuke Tanaka, Kentaro Takeda, Ryo Kitabayashi, Hiroyuki Sato, Akihiro Hirakawa. BOIN12‐PFS: A Bayesian Optimal Interval Phase I/II Design Incorporating Progression‐Free Survival Endpoint. // Pharmaceutical Statistics. – 2026. – DOI: 10.1002/pst.70133. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pst.70133?af=R
Yusuke Tanaka, Kentaro Takeda, Ryo Kitabayashi, Hiroyuki Sato, & Akihiro Hirakawa (2026). BOIN12‐PFS: A Bayesian Optimal Interval Phase I/II Design Incorporating Progression‐Free Survival Endpoint. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70133
Yusuke Tanaka, et al. “BOIN12‐PFS: A Bayesian Optimal Interval Phase I/II Design Incorporating Progression‐Free Survival Endpoint.” Pharmaceutical Statistics, 2026. doi:10.1002/pst.70133.
@article{Tanaka2026,
title = {BOIN12‐PFS: A Bayesian Optimal Interval Phase I/II Design Incorporating Progression‐Free Survival Endpoint},
author = {Tanaka, Yusuke and Takeda, Kentaro and Kitabayashi, Ryo and Sato, Hiroyuki and Hirakawa, Akihiro},
journal = {Pharmaceutical Statistics},
year = {2026},
doi = {10.1002/pst.70133},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pst.70133?af=R}
}